Эндотелиальная дисфункция у больных с острым инфарктом миокарда с подъемом сегмента ST

Авторы: И. Л. Уразовская

Организация:
Кафедра кардиологии ФПДО Московского государственного медико-стоматологического университета

Для корреспонденции: Сведения доступны для зарегистрированных пользователей.

Тип статьи: Острый коронарный синдром

Цитировать как: И. Л. Уразовская. Эндотелиальная дисфункция у больных с острым инфарктом миокарда с подъемом сегмента ST. . DOI:

Полнотекстовая версия:  

Литература

1. Бувальцев, В. И. Дисфункция эндотелия как новая концепция профилактики и лечения сердечно-сосудистых заболеваний / В. И. Бувальцев // Междунар. мед. журн. – 2001. – № 3. – С. 202–209.

2. Затейщикова, А. А. Эндотелиальная регуляция сосудистого тонуса: методы исследования и клиническое значение / А. А. Затейщикова, Д. А. Затейщиков // Кардиология. – 1998. – Т. 38, № 9. – С. 68–80.

3. Мкртумян, А. М. Роль дисфункции эндотелия в развитии гемодинамических нарушений и поздних сосудистых осложнений у больных сахарным диабетом 2-го типа / А. М. Мкртумян, А. Л. Давыдов, Р. И. Стрюк, М. Л. Полукаров // Рос. мед. вести. – 2008. – № 13. – С. 36–48.

4. Ющук, Е. Н. Эндотелиальная дисфункция при заболеваниях сердечно-сосудистой системы и методы ее коррекции / Е. Н. Ющук, Ю. А. Васюк, А. Б. Хадзегова и др. // Клин. фармакол. и тер. – 2005. – Т. 14, № 3. – С. 85–88.

5. Amir, O. Brachial reactivity and extent of coronary artery disease in patients with first ST-elevation acute myocardial infarction / O. Amir, R. Jaffe, А. Shiran et al. // Am. J. Cardiol. – 2006. – Vol. 98. – P. 754–757.

6. Andreotti, F. Early coronary reperfusion blunts the procoagulant response of plasminogen activator-1 and von Willebrand factor in acute myocardial infarction / F. Andreotti, M. Roncaglioni, D. Hackett et al. // J. Am. Coll. Cardiol. – 1990. – Vol. 16. – P. 239–243.

7. Augustin, H. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes / H. Augustin, D. Kozian, R. Johason // Bioessays. – 1994. –Vol. 16. – P. 901–906.

8. Behrendt, D. Endothelial function: from vascular biology to clinical application / D. Behrendt, P. Ganz // Am. J. Cardiol. – 2002. – Vol. 90. – P. 40L–48L (Suppl.).

9. Bonetti, P. Endothelial dysfunction: a marker of atherosclerotic risk / P. Bonetti, L. Lerman, A. Lerman et al. // Arterioscler. Thromb. Vasc. Biol. – 2003. – Vol. 23. – P. 168–175.

10. Celermajer, D. Non-invasive detection of endothelial dysfunction in children and adult at risk of atherosclerosis / D. Сelermajer, K. Sorensen, V. Gooch et al. // Lancet. – 1992. – Vol. 340. – P. 1111–1115.

11. Celermajer, D. Passive smoking and impaired endothelium-dependent arterial dilation in healthy young adults / D. Сelermajer, M. Adams, P. Clarkson et al. // N. Engl. J. Med. – 1996. – Vol. 334. – P. 150–154.

12. Chang, P. Plasma derived von Willebrand factor preparations: collagen binding and ristocetin cofactor activities / P. Chang, D. Aronson // Throm. Haemost. – 1997. – Vol. 78. – P. 930–933.

13. Christian, T. F. Prevalence of spontaneous reperfusion and associated myocardial salvage in patients with acute myocardial infarction / T. F. Christian, J. J. Milavetz, T. D. Miller et al. // Am. Heart J. – 1998. – Vol. 135. – P. 421–427.

14. Cines, D. Endothelial cells in physiology in the pathophysiology of vascular disorders / D. Cines, E. Pollak, C. Buck et al. // Blood. – 1998. – Vol. 91. – P. 3527–3561.

15. Collen, D. The plasminogen (fibrinolytic) system / D. Collen // Thromb. Haemost. – 1999. – Vol. 82. – P. 259–270.

16. Collet, J. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality / J. Collet, G. Montalescot, E. Vicaut et al. // Circulation. – 2003. – Vol. 108. – P. 391–394.

17. Cortellaro, M. The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principle results / M. Cortellaro, C. Boschetti, E. Cofrancesco et al. // Arterioscler. Thromb. – 1992. – Vol. 12. – P. 1063–1070.

18. Davignon, J. Role of endothelial dysfunction in atherosclerosis / J. Davignon, P. Ganz // Circulation. – 2004. – Vol. 109. – P. III-27–III-32 (Suppl. 3).

19. Deanfield, J. H. Endothelial function and dysfunction Testing and clinical relevance / J. H. Deanfield, T. Rabelink // Circulation. – 2007. – Vol. 115. – P. 1285–1295.

20. DeWood, M. Coronary arteriographic findings in acute transmural myocardial infarction / M. De- Wood, J. Spores, G. Hensley et al. // Circulation. – 1983. – Vol. 68. – P. I39–I49 (Suppl. 1).

21. Diamant, M. Cellular microparticles: new players in the field of vascular disease? / M. Diamant, M. Tushuizen, A. Sturk et al. // Eur. J. Clin. Invest. – 2004. – Vol. 34. – P. 92–401.

22. Donald, A. Non-invasive assessment of endothelial function: which technique? / A. Donald, M. Charakida, T. Cole et al. // J. Am. Coll. Cardiol. – 2006. – Vol. 48. – P. 1846–1850.

23. Drexler, H. Factors involved in the maintenance of endothelial function / H. Drexler // Am. J. Cardiol. – 1998. – Vol. 82. – P. 3S–4S.

24. Emeris, J. An endothelial storage granule for tissuetype plasminogen activator / J. Emeris, Y. van den Eijnden-Schrauwen, C. van den Hoogen et al. // J. Cell. Biol. – 1997. – Vol. 139. – P. 245–256.

25. Esper, R. Endothelial dysfunction: a comprehensive appraisal / R. Esper, R. Nordaby, J. Vilarino et al. // Cardiovasc. Diabetol. – 2006. – Vol. 5. – P. 4.

26. Fathi, R. The relative importance of vascular structure and function in predicting cardiovascular events / R. Fathi, B. Haluska, N. Isbel et al. // J. Am. Coll. Cardiol. – 2004. – Vol. 43. – P. 616–623.

27. Fever, P. Relation of clinically defined spontaneous reperfusion to outcome in ST-elevation myocardial infarction / P. Fever, H. Hod, H. Hammerman et al. // Am. J. Cardiol. – 2009. – Vol. 103. – P. 149–153.

28. Fuster, V. Acute coronary syndromes: biology / V. Fuster, Z. Fayad, J. Badimon // Lancet. – 1999. – Vol. 353. – P. S115–S119 (Suppl. 2).

29. Gimbrone, M. Vascular endothelium, hemodynamic forces, and angiogenesis / M. Gimbrone // Am. J. Pathol. – 1999. – Vol. 155. – P. 1–5.

30. Guazzi, M. Prognostic value of flow-mediated dilatation following myocardial infarction / M. Guazzi, G. Reina, P. Gripari et al. // Int. J. Cardiol. – 2009. – Vol. 132. – P. 45–50.

31. Halcox, J. Prognostic value of coronary vascular endothelial function / J. Halcox, W. Schenk, G. Zalos et al. // Circulation. – 2002. – Vol. 106. – P. 653–658.

32. Hansson, G. Inflammation, atherosclerosis, and coronary artery disease / G. Hansson // N. Engl. J. Med. – 2005. – Vol. 352. – P. 1685–1883.

33. Heitzer, T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease / T. Heitzer, T. Schlinzig, K. Krohn et al. // Circulation. – 2001. – Vol. 104. – P. 2673–2678.

34. Howard, M. Ristocetin: a new tool in the investigation of platelet aggregation / M. Howard, B. Firkin // Thromb. Diath. Haemorrh. – 1971. – Vol. 26. – P. 362–369.

35. Huisse, M.-G. Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction / M.-G. Huisse, E. Lanoy, D. Tcheche et al. // Thromb. Haemost. – 2007. – Vol. 98. – P. 420–426.

36. Hwang, S. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerotic and incident coronary heart disease cases: the Atherosclerotic Risk In Communities (ARIC) study / S. Hwang, C. Ballantyne, A. Scharrett et al. // Circulation. – 1997. – Vol. 16. – P. 4219–4225.

37. Ishihara, M. Impact of spontaneous anterograde flow of the infarct artery on left ventricular function in patients with a first anterior wall acute myocardial infarction / M. Ishihara, I. Inoue, T. Kawagoe et al. // Am. J. Cardiol. – 2002. – Vol. 90. – P. 5–9.

38. Iwakura, K. Detection of TIMI-3 flow before mechanical reperfusion with ultrasonic tissue characterization in patients with anterior wall acute myocardial infarction / K. Iwakura, H. Ito, S. Kawano et al. // Circulation. – 2003. – Vol. 107. – P. 3159–3164.

39. Jansson, J. Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death / J. Jansson, T. Nilsson, O. Johnson // Br. Heart J. – 1991. – Vol. 66. – P. 351–355. 40. Karatzis, E. N. Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation / E. N. Karatzis, I. Ikonomidis, G. D. Vamvakou et al. // Am. J. Cardiol. – 2006. – Vol. 98, № 11. – P. 1424–1428.

41. Kitta, Y. Persistent impairment of endothelial vasomotor function has negative impact on outcome in patients with coronary artery disease / Y. Kitta, J. Obata, T. Nakamura et al. // J. Am. Coll. Cardiol. – 2009. – Vol. 53. – P. 323–330.

42. Kohler, H. Plasminogen-activator inhibitor type 1 and coronary artery disease / H. Kohler, P. Grant // N. Engl. J. Med. – 2000. – Vol. 342. – P. 1792–1801.

43. Kurowski, V. The effects of facilitated primary PCI by guide wire on procedural and clinical outcomes in acute ST-segment elevation myocardial infarction / V. Kurowski, E. Giannitsis, D. Killermann et al. // Clin. Res. Cardiol. – 2007. – Vol. 96. – P. 557–565.

44. Lee, C. W. Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction / C. W. Lee, M. K. Hong, J. H. Lee et al. // Am. J. Cardiol. – 2001. – Vol. 87. – P. 951–954.

45. Lee, K. W. Plasma markers of endothelial damage/ dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes / K. W. Lee, A. D. Blann, G. Y. Lip // Thromb. Haemost. – 2005. – Vol. 94, № 5. – P. 1077–1083.

46. Libby, P. Pathophysiology of coronary artery disease / P. Libby, P. Theroux // Circulation. – 2005. – Vol. 111. – P. 3481–3488.

47. Luscher, T. Biology of the endothelium / T. Luscher, M. Barton // Clin. Cardiol. – 1997. – Vol. 20. – P. II-3–II-10 (Suppl. 2).

48. Montalescot, G. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angine / G. Montalescot, J. Collet, L. Lison et al. // J. Am. Coll. Cardiol. – 2000. – Vol. 36. – P. 110–114.

49. Naghavi, M. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I / M. Naghavi, P. Libby, E. Falk et al. // Circulation. – 2003. – Vol. 108. – P. 1664–1672.

50. Pasceri, V. ETH Y Direct proinflammatory effect of C-reactive protein on human endothelial cells / V. Pasceri, J. Willerson // Circulation. – 2000. – Vol. 102. – P. 2165–2168.

51. Patti, G. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation / G. Patti, V. Pasceri, R. Melfi et al. // Circulation. – 2005. – Vol. 111. – P. 70–75.

52. Rassaf, T. Circulating NO pool: assesstment of nitrite and nitroso species I blood and tissues / T. Rassaf, M. Feelisch, M. Kelm // Free. Radic. Biol. Med. – 2004. – Vol. 36. – P. 413–422.

53. Regieli, J. J. Coronary collaterals improve prognosis in patients with ischemic heart disease / J. J. Regieli, J. W. Jukema, H. M. Nathoe et al. // Int. J. Cardiol. – 2009. – Vol. 132, № 2. – P. 257–262.

54. Rernandez-Ortiz, A. Characterization of the relative thrombogenicity of atherosclerotic plaque contents: implications for consequences of plaque rupture / A. Rernandez-Ortiz, J. Badimon, E. Falk et al. // J. Am. Coll. Cardiol. – 1994. – Vol. 23. – P. 1562–1569.

55. Ridker, P. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events / P. Ridker, N. Brown, D. Vaughan et al. // Circulation. – 2004. – Vol. 109. – P. IV6–IV19 (Suppl. 4).

56. Rifai, N. Inflammatory markers and coronary heart disease / N. Rifai, P. Ridker // Curr. Opin. Lipidol. – 2002. – Vol. 13. – P. 383–389.

57. Rubanyi, G. The role of endothelium in cardiovascular homeostasis and diseases / G. Rubanyi // J. Cardivasc. Pharmacol. – 1993. – Vol. 22. – P. S1–S14 (Suppl. 4).

58. Schachinger, V. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease / V. Schachinger, M. Britten, M. Elsner et al. // Circulation. – 1999. – Vol. 100. – P. 1502–1508.

59. Schini-Kerth, V. Vascular biosynthesis of nitric oxide: effect of hemostasis and fibrinolysis / V. Schini-Kerth // Transfus. Clin. Biol. – 1999. – Vol. 6. – P. 355–363.

60. Steg, P. Conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery / P. Steg, D. Himbert, H. Benamer et al. // Am. Heart J. – 1997. – Vol. 134. – P. 248–252.

61. Suwaidi, A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction / A. Suwaidi, S. Hamasaki, S. Higano et al. // Circulation. – 2000. – Vol. 101. – P. 948–954.

62. Taher, T. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regiment-3 rial Electrocardiographis Substudy / T. Taher, Y. Fu, G. Wagner et al. // J. Am. Coll. Cardiol. – 2004. – Vol. 44. – P. 38–43.

63. Van Hinsbergh, V. The endothelium: vascular control of haemostasis / V. van Hinsbergh // Eur. J. Obstetrics Gynecol. Reproduct. Biol. – 2002. – Vol. 95. – P. 198–201.

64. Vanhoutte, P. How to assess endothelial function in human blood vessels / P. Vanhoutte // J. Hypertension. – 1999. – Vol. 17. – P. 1047–1058.

65. Vasilieva, E. Platelet function in patients plasma lipid levels in patients with stable and unstable angine pectoris / E. Vasilieva, A. Shpector, A. Raskuragev et al. // Am. J. Cardiol. – 1991. – Vol. 68. – P. 959–966.

66. Vaughan, D. PAI-1 and atherothrombosis / D. Vaughan // J. Thromb. Haemost. – 2005. – Vol. 3. – P. 1879–1883.

67. Venugopal, S. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells / S. Venugopal, S. Devaraj, I. Yuhanna et al. // Circulation. – 2002. – Vol. 106. – P. 1439–1441.

68. Verma, S. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis / S. Verma, C.-H. Wang, S.-H. Li et al. // Circulation. – 2002. – Vol. 106. – P. 913–919.

69. Virmani, R. Lesion from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesion / R. Virmani, F. Kolodgies, A. Burke et al. // Arterioscler. Thromb. Vasc. Boil. – 2000. – Vol. 20. – P. 1262–1275.

70. Werner, N. Circulating CD31+/annexin V+ apoptic microparticles correlate with coronary endothelial function in patients with coronary artery disease / N. Werner, S. Wassmann, P. Ahlers et al. // Arterioscler. Vasc. Biol. – 2006. – Vol. 26. – P. 112–116.

Электронная подписка

Для получения доступа к тексту статей журнала воспользуйтесь услугой «Электронная подписка»:

Оформить подписку Подробнее об электронной подписке

Главный редактор

Лео Антонович Бокерия, академик РАН и РАМН

Лео Антонович Бокерия, доктор медицинских наук, профессор, академик РАН и РАМН, директор


 Если вы заметили опечатку, выделите текст и нажмите alt+A